Loading clinical trials...
Loading clinical trials...
The study will evaluate the safety and tolerability, optimal biologic dose, and pharmacokinetics of eltrombopag for patients with advanced sarcoma who have a low platelet count and are receiving ADRIA...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT06805097 · Thrombocytopaenia, Haematological Malignancies
NCT01957176 · Thrombocytopaenia
NCT02158936 · Thrombocytopaenia
NCT01657552 · Thrombocytopaenia
NCT01235988 · Thrombocytopaenia
GSK Investigational Site
Santa Monica, California
GSK Investigational Site
Miami, Florida
GSK Investigational Site
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions